Partnership for Safe Medicines Condemns the Weakening of the U.S. Drug Supply through Canadian Drug Importation + Full coverage of decision

Shabbir Safdar, executive director of the Partnership for Safe Medicines, released the following statement in response to the U.S. Food and Drug Administration’s final decision to approve Florida’s Canadian drug importation plan.

“The United States government’s decision to approve Florida’s Canadian drug importation plan weakens our nation’s safe drug supply, putting American patients at risk. This decision breaks our closed loop system and opens the door to counterfeiters and others who will be more than happy to meet demand. By design, Florida’s plan puts our most vulnerable patient communities – such as people living with HIV – at risk.”

PSM continues to track importation proposals across the country and works to educate patients and policymakers about the risks of purchasing medicines from online pharmacies. For more information and to find resources about counterfeit drugs and more, visit or contact

Official documents

From the FDA: Approval letter to Florida authorizing their SIP application [PDF], Press release regarding approval, FDA information page on Section 804 programs

From Florida: Nov 20, 2023 SIP application that was approved [PDF not available yet].

Statements from stakeholders

Media coverage and Op-eds